OPEN END TURBO LONG - COOPER COMPANIES Share Price

Certificat

DE000MG2WUV1

Real-time Bid/Ask 17:02:42 06/06/2024 BST
0.133 EUR / 0.136 EUR +7.14% Intraday chart for OPEN END TURBO LONG - COOPER COMPANIES
Current month-2.33%
1 month+24.75%
Date Price Change
06/06/24 0.132 +4.76%
05/06/24 0.126 -3.08%
04/06/24 0.13 -0.76%
03/06/24 0.131 +1.55%
31/05/24 0.129 +40.22%

Delayed Quote Börse Stuttgart

Last update June 06, 2024 at 03:28 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying THE COOPER COMPANIES, INC.
Issuer Morgan Stanley
WKN MG2WUV
ISINDE000MG2WUV1
Date issued 24/04/2024
Strike 80.94 $
Maturity Unlimited
Parity 100 : 1
Emission price 0.1
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.167
Lowest since issue 0.077
Spread 0.003
Spread %2.19%

Company Profile

The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision and CooperSurgical. CooperVision is engaged in the contact lens industry. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys, Biofinity toric & Biofinity XR toric, Biofinity multifocal, Biofinity toric multifocal, clariti 1 day, clariti 1 day toric, clariti 1 day multifocal, MiSight 1 day, Avaira Vitality and Avaira Vitality toric. CooperSurgical is a fertility and women’s health company dedicated to assisting women, babies and families around the world. CooperSurgical provides a range of products and services with an emphasis on improving fertility solutions, empowering office-based care, and advancing hospital care within women’s health. CooperSurgical’s brands include Paragard, ER-Complete, Fetal Pillow, INSORB, PGT-Complete, RUMI II and others.
Sector
-
More about the company

Ratings for The Cooper Companies, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: The Cooper Companies, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
94.23 USD
Average target price
108.2 USD
Spread / Average Target
+14.78%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW